scholarly article | Q13442814 |
P2093 | author name string | Tikoo A | |
Ramesh V | |||
Varga M | |||
Gusella J | |||
Maruta H | |||
P433 | issue | 38 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurofibromatosis type II | Q1935832 |
P304 | page(s) | 23387-23390 | |
P577 | publication date | 1994-09-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin) | |
P478 | volume | 269 |
Q24533435 | Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains |
Q22253159 | Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins |
Q92637203 | Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis |
Q41834097 | Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity |
Q42827339 | Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. |
Q40370592 | Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes |
Q24617964 | Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site |
Q34145489 | Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations |
Q24338893 | Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein |
Q30495325 | Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation |
Q24648337 | Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation |
Q35049697 | Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin |
Q28283076 | Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival |
Q38105985 | Merlin, the NF2 Gene Product |
Q38023101 | Merlin: The wizard requires protein stability to function as a tumor suppressor |
Q30457681 | Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms |
Q47212698 | Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review). |
Q30498854 | Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton |
Q26825296 | Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator |
Q30486851 | Reduced expression of neurofibromin in human meningiomas |
Q38979328 | Regulation ofDrosophilaglial cell proliferation by Merlin-Hippo signaling |
Q36189820 | Role of Merlin/NF2 inactivation in tumor biology |
Q39575140 | Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation. |
Q71131047 | Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas |
Q34658335 | Silencing of CD44 Gene Expression in Human 143-B Osteosarcoma Cells Promotes Metastasis of Intratibial Tumors in SCID Mice |
Q33707642 | The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression |
Q91937389 | The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling |
Q41814702 | The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner |
Q24650089 | The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP |
Q54774110 | The phosphorylation status of merlin in sporadic vestibular Schwannomas. |
Q28590774 | The tumor suppressor merlin is required for cell cycle exit, terminal differentiation, and cell polarity in the developing murine lens |
Search more.